In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals

被引:4
作者
Karakucuk, Alptug [1 ,2 ]
Tashan, Emine [1 ,3 ]
Ozturk, Naile [4 ]
Celebi, Nevin [1 ,5 ]
机构
[1] Gazi Univ, Dept Pharmaceut Technol, Fac Pharm, Ankara, Turkey
[2] Ankara Medipol Univ, Dept Pharmaceut Technol, Fac Pharm, Ankara, Turkey
[3] Zoleant Pharmaceut Int, Istanbul, Turkey
[4] Inonu Univ, Dept Pharmaceut Technol, Fac Pharm, Malatya, Turkey
[5] Baskent Univ, Dept Pharmaceut Technol, Fac Pharm, Ankara, Turkey
关键词
Caco-2; cells; permeability; ziprasidone; nanocrystal; DRUG NANOCRYSTALS; NANOSUSPENSIONS; DELIVERY; OPTIMIZATION; DISSOLUTION; ABSORPTION; TRANSPORT; DESIGN;
D O I
10.4274/tjps.galenos.2020.67366
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: The current study focused on the evaluation of the cytotoxic effect and permeability of ziprasidone hydrochloride monohydrate (ZHM) nanocrystals on Caco-2 cells. Materials and Methods: ZHM nanocrystals were prepared by the microfluidization method in the presence of polyvinylpyrrolidone as a stabilizer. Particle size (PS), particle size distribution (PDI), and zeta potential (ZP) values were measured in characterization studies. In vitro cytotoxic effects of ZHM nanocrystals were investigated using the 3-(4,5-dimetylthiazol-2-yl)-2,5-diphenyltetrazolium bromide test. Caco-2 transport studies were conducted with formulations of ZHM coarse powder and nanocrystals. Results: Nanocrystals were obtained with 400-600 nm PS, 0.1-0.4 PDI, and >20 mV ZP values. The cell viability remained 100% for all sample groups. The permeability value of ZHM nanocrystals through Caco-2 cells increased 2.3-fold in comparison with ZHM coarse powder. Cumulative drug transport also increased at the end of the sampling period. Conclusion: Nanocrystal technology helps to increase the permeability of drug particles by increasing the saturation solubility.
引用
收藏
页码:223 / 227
页数:5
相关论文
共 29 条
  • [21] Development of Nanocrystal Ziprasidone Orally Disintegrating Tablets: Optimization by Using Design of Experiment and In Vitro Evaluation
    Tashan, Emine
    Karakucuk, Alptug
    Celebi, Nevin
    [J]. AAPS PHARMSCITECH, 2020, 21 (03)
  • [22] Optimization and in vitro evaluation of ziprasidone nanosuspensions produced by a top-down approach
    Tashan, Emine
    Karakucuk, Alptug
    Celebi, Nevin
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2019, 52 : 37 - 45
  • [23] In vitro and in vivo characterization of amorphous, nanocrystalline, and crystalline ziprasidone formulations
    Thombre, Avinash G.
    Shah, Jaymin C.
    Sagawa, Kazuko
    Caldwell, W. Brett
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 428 (1-2) : 8 - 17
  • [24] Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model
    Wahlang, Banrida
    Pawar, Yogesh B.
    Bansal, Arvind K.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 77 (02) : 275 - 282
  • [25] Development of daidzein nanosuspensions: Preparation, characterization, in vitro evaluation, and pharmacokinetic analysis
    Wang, Hui
    Xiao, Yi
    Wang, Hai
    Sang, Zechun
    Han, Xiaole
    Ren, Shuzhen
    Du, Ruofei
    Shi, Xiufeng
    Xie, Yan
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 566 : 67 - 76
  • [26] A new understanding of the relationship between solubility and particle size
    Wu, WJ
    Nancollas, GH
    [J]. JOURNAL OF SOLUTION CHEMISTRY, 1998, 27 (06) : 521 - 531
  • [27] In vitro permeability across Caco3 cells (colonic) can predict in vivo (small intestinal) absorption in man - Fact or myth
    Yee, SY
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (06) : 763 - 766
  • [28] The Improvement of the Dissolution Rate of Ziprasidone Free Base from Solid Oral Formulations
    Zakowiecki, Daniel
    Cal, Krzysztof
    Kaminski, Kamil
    Adrjanowicz, Karolina
    Swinder, Lech
    Kaminska, Ewa
    Garbacz, Grzegorz
    [J]. AAPS PHARMSCITECH, 2015, 16 (04): : 922 - 933
  • [29] Nanocrystals of medium soluble actives-Novel concept for improved dermal delivery and production strategy
    Zhai, Xuezhen
    Lademann, Juergen
    Keck, Cornelia M.
    Mueller, Rainer H.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 470 (1-2) : 141 - 150